Our Company

Ajay is an expert in cell-based diagnostic technologies, as well as an experienced entrepreneur, having previously co-founded two life science companies (one acquired in 2012). Ajay received his PhD from the Harvard-MIT Division of Health Sciences and Technology, where he developed a novel platform for circulating tumor cell isolation under the supervision of Mehmet Toner and Daniel Haber at Massachusetts General Hospital.

Henry leads research and development efforts to commercialize the microfluidic deformability cytometry technology. His science and engineering expertise spans microfluidics, cancer biology, image processing, and application proof-of-concept clinical studies. Henry is the co-inventor of the deformability cytometry platform, which has resulted in peer-reviewed publications of the technology, as well an accompanying suite of issued patents. Henry holds a BS in Bioengineering and Biomedical Engineering from the University of California San Diego and a PhD in Biomedical Engineering from the University of California Los Angeles.

Bill is a tenured medtech executive with broad experience across finance and general management. Over the past twenty years, Bill was an auditor at KPMG, served in a variety of roles at CareFusion/Becton Dickinson, and most recently led finance at Pfenex Biopharmaceuticals (Nasdaq: PFNX) until its acquisition in late 2020. Notably, in addition to several accounting and finance roles, Bill has operations experience (including serving as VP Global Business Operations, Dispensing Technologies at BD). In these operating roles, Bill has helped secure several large health system technology agreements, led a business model transformation of BD’s Pyxis Enterprise Solution business, managed efforts in the federal government segment, and restructured the product release and product lifecycle management processes.

Fe Batara serves as Chief People Officer at Cytovale, where she leads the company’s people strategy, executive talent, organizational effectiveness, culture, compliance, and corporate governance in support of the company’s mission to transform the diagnosis of sepsis. She partners with executive leadership on organizational strategy, executive development, succession planning, leadership effectiveness, and organizational design to build a high-performing company positioned for long-term growth.

With more than 25 years of executive human resources experience in the biopharmaceutical, diagnostics, and life sciences industries, Fe has successfully guided organizations through rapid growth, commercialization, organizational transformation, and executive leadership transitions. Her expertise spans executive coaching, organizational design, workforce strategy, talent acquisition, executive compensation, governance, and building high-performing cultures that enable businesses to scale.

Prior to joining Cytovale, Fe served as Vice President, Head of Human Resources at HUYABIO International and held senior human resources leadership positions at Genoptix/Novartis, Celgene, and Quest Diagnostics. She is passionate about fostering purpose-driven cultures rooted in accountability, ownership, and innovation while helping leaders and organizations achieve their full potential.

Fe holds a Master of Business Administration from San Francisco State University and a Master of Science in Human Resources Management from National University.

Eric Khairy is a mission-driven strategic executive with deep experience in operations and commercial execution over his 20+ year career in MedTech. Eric joined Cytovale from Inari Medical where he served as Senior Vice President of Marketing and Commercial Operations, helping to fuel the company’s growth from $6 million to $600 million in annual revenue over his seven-year tenure, from startup through a $1 billion IPO and subsequent $4.9 billion acquisition by Stryker. Prior to Inari, he held commercial and strategy leadership roles at Philips, Volcano, Corindus Vascular Robotics, and Minogue Medical. Eric holds an MBA from MIT, an M.A.Sc. in biomedical engineering from the University of Montreal, and a B.Eng. in computer engineering from McGill University.

Roya Ira, PhD, is Executive Vice President of Medical & Scientific Affairs at Cytovale, where she leads the company’s medical affairs strategy and contributes to the advancement of evidence-based approaches to early disease detection. She brings deep expertise at the intersection of biomedical engineering, clinical medicine, and data science, with a focus on translating complex biological signals into clinically actionable diagnostic insights.

Roya earned her BSc, MSc, and PhD in Biomedical Engineering from the University of Southern California. Her doctoral research focused on the design and characterization of wireless implantable drug delivery systems for patient-tailored therapy. She later received the inaugural Hibbitt Engineering Postdoctoral Fellowship at Brown University, where she advanced the development of wearable biosensors and responsive hydrogels for wound management. At Cytovale, she has helped shape diagnostic model development by applying machine learning and feature engineering methodologies alongside extensive knowledge of dysregulated immune system biology and clinical data derived from multiple clinical studies.

In her current role, Roya oversees Cytovale’s Medical Affairs function, including field medical engagement, clinical research and publication strategy, implementation and clinical transformation support, and the continued development of clinical data science capabilities that reinforce confidence in IntelliSep.

Valerie Taylor, MBA serves as Senior Vice President, Sales at Cytovale, where she leads the company’s national sales organization and commercial strategy to accelerate adoption of IntelliSep and expand access to innovative diagnostic solutions that improve patient care. With more than 18 years of healthcare commercial leadership experience, Valerie has built and transformed high-performing sales organizations across diagnostics, medical devices, digital health, and other regulated markets. She has generated more than $5 billion in revenue, led enterprise sales organizations responsible for multi-hundred-million-dollar portfolios, and consistently delivered growth by developing strategic customer partnerships, expanding market access, and building winning teams.

Prior to Cytovale, Valerie held executive sales leadership roles at Abbott Laboratories and Ortho Clinical Diagnostics, where she earned a reputation for turning around underperforming businesses, securing landmark health system partnerships, and driving sustainable commercial growth. She holds an MBA from Rochester Institute of Technology and a bachelor’s degree from the State University of New York at Brockport.